Navigation Links
Undiscovered Companies Announces A Video Interview Of Hidden Bio-Tech Company Immunotech Laboratories
Date:1/31/2013

LAS VEGAS, Jan. 31, 2013 /PRNewswire/ -- Recently Immunotech Laboratories (IMMB) President Harry Zhabilov and Director Bo Linton welcomed UndiscoveredCompanies.com into their facilities to conduct an interview.

The video interview went very well.  Some of the topics discussed were the Company's Present and Future Goals, Expansion of Treatments, Potential Revenues, Medical Advisory Board, and FDA Approval.  The first part of this interview featuring Company Director Mr. Bo Linton can be viewed at http://www.youtube.com/watch?v=uCjNAf30aeo as well as on the Undiscovered Company website.  The second part featuring the company CEO Harry Zhabilov will be released in a separate announcement.

In 2012 Undiscovered Companies reported on several other companies in the Bio-Tech Sector including TNI BioTech, Inc. (TNIB), which has recently come down from a 52 Week High of $10.20 as shown on Yahoo Finance http://finance.yahoo.com/q?s=TNIB

PREVIOUS ANNOUNCEMENT FOLLOW  UP

Previous companies announced by Undiscovered Companies are doing very well.

Swingplane Ventures Inc. (SWVI) announced problems with their website, but the problems have since been resolved.  The company booked 1884 trades in Wednesday's trading session.

A.P. Pharma (APPA) hit a new 52 week high of 88 cents on Wednesday and closed at $0.79.  The company has been very active for several months now.  A. P. Pharma engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology

About Immunotech Laboratories

Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases suck as HIV, Cancer, Hepatitis and Aids. Immunotech is committed to creating drugs for the better health of mankind.

About Undiscovered Companies

Undiscovered Companies is a video news provider of public and private companies looking for new marketing ideas and product exposure.

Safe Harbor Statement: This release may include the use of forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Disclosure: UndiscoveredCompanies.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit our website for complete risks and disclosures.

Contact
Immunotech Laboratories
IR@immunotechlab.com

Contact
Undiscovered Companies
info@undiscoveredcompanies.com

CSNNewswire.com
info@csnnewswire.com


'/>"/>
SOURCE Undiscovered Companies
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
2. Lucintel Profiles Top Five Global Polypropylene Companies: APAC is Expected to Drive Future Industry Growth
3. California Biomedical Companies Report Higher Product Approvals, Fewer Delays
4. Embedded Recruiter Digital Prospectors Corp Named One of NH's Top Small Companies to Work for Again
5. Lucintel Performs Competitive Analysis on Top Five Global Consumer Electronic Companies
6. Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
7. Ten Pharmaceutical Companies Unite to Accelerate Development of New Medicines
8. Companies Selected to Present at AdvaMed 2012 Announced
9. AllCells, LLC Named to Inc. Magazines 500/5000 List of Fastest Growing Companies
10. Seahorse Bioscience Ranks No. 1600 on the Inc. 500
11. 5000 List of Fastest-Growing Private Companies in America for 2012 with Three-Year Sales Growth of 183%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Dec. 6, 2016 The American Botanical Council ... of arnica ( Arnica montana ) through ABC,s ... HerbMedPro database, a comprehensive, interactive online ... clinical research data on the uses and health ... Naturopathica, a wellness company with healing arts ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... 1, 2016 asking the Federal Drug Administration (FDA) to consider OA as a ... OARSI is concerned about the growing population of OA patients, many of whom ...
(Date:12/6/2016)... Collins, Colorado (PRWEB) , ... December 06, 2016 ... ... of dynamic aqueous plasma technology platforms, announced today that the company has engaged ... Master Research and Development Agreement (MRDA) with the CSU Office of the Vice ...
(Date:12/6/2016)... , Dec. 6, 2016  Creative Medical Technology ... , MD, PhD, FANA, FAAN to the Company,s Scientific ... and clinical trials to assist the Company,s clinical development ... AmnioStem product is a universal donor stem cell derived ... in animal models of stroke 1 .  ...
Breaking Biology Technology:
(Date:11/22/2016)... MINNETONKA, Minn. , Nov. 22, 2016   ... that supports the entire spectrum of clinical research, is ... by Medical LiveWire Healthcare and Life Sciences Awards ... This award caps off an unprecedented year of recognition ... clinical trials for over 15 years. iMedNet ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
Breaking Biology News(10 mins):